139 related articles for article (PubMed ID: 38159412)
1. Perioperative acute kidney injury: The renoprotective effect and mechanism of dexmedetomidine.
Gao X; Wu Y
Biochem Biophys Res Commun; 2024 Feb; 695():149402. PubMed ID: 38159412
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion.
Li Q; Chen C; Chen X; Han M; Li J
Life Sci; 2018 Aug; 207():1-8. PubMed ID: 29729264
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia-Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling.
Bao N; Tang B; Wang J
J Immunol Res; 2020; 2020():3230490. PubMed ID: 32377532
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Alleviates Ischemia/Reperfusion-Associated Acute Kidney Injury by Enhancing Autophagic Activity
Zhou BY; Yang J; Luo RR; Sun YL; Zhang HT; Yang AX; Zhang GX
Front Biosci (Landmark Ed); 2023 Dec; 28(12):323. PubMed ID: 38179733
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats.
Bao N; Dai D
Mediators Inflamm; 2020; 2020():2120971. PubMed ID: 32317860
[TBL] [Abstract][Full Text] [Related]
7. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective effects of dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats.
Kim SH; Jun JH; Oh JE; Shin EJ; Oh YJ; Choi YS
PLoS One; 2018; 13(8):e0198307. PubMed ID: 30114208
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway.
Feng X; Guan W; Zhao Y; Wang C; Song M; Yao Y; Yang T; Fan H
J Cell Physiol; 2019 Aug; 234(10):18994-19009. PubMed ID: 30919976
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α
Sun Q; Kamath P; Sun Y; Liang M; Wu L; Chang E; Chen Q; Alam A; Liu Y; Zhao H; Ma D
Biomed Pharmacother; 2024 May; 174():116462. PubMed ID: 38513598
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7 nAChR-dependent pathway.
Kang K; Gao Y; Wang SC; Liu HT; Kong WL; Zhang X; Huang R; Qi ZD; Zheng JB; Qu JD; Liu RJ; Liu YS; Wang HL; Yu KJ
Biomed Pharmacother; 2018 Oct; 106():210-216. PubMed ID: 29960167
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS/NO signaling pathway in rats.
Chen Y; Luan L; Wang C; Song M; Zhao Y; Yao Y; Yang H; Ma B; Fan H
Nitric Oxide; 2019 Apr; 85():1-9. PubMed ID: 30659917
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine alleviates cisplatin‑induced acute kidney injury by attenuating endoplasmic reticulum stress‑induced apoptosis via the α2AR/PI3K/AKT pathway.
Chai Y; Zhu K; Li C; Wang X; Shen J; Yong F; Jia H
Mol Med Rep; 2020 Mar; 21(3):1597-1605. PubMed ID: 32016445
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice.
Gu J; Sun P; Zhao H; Watts HR; Sanders RD; Terrando N; Xia P; Maze M; Ma D
Crit Care; 2011 Jun; 15(3):R153. PubMed ID: 21702944
[TBL] [Abstract][Full Text] [Related]
15. Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?
Erkılıç E; Kesimci E; Alaybeyoğlu F; Kılınç I; Tural R; Yazgan A; Gümüş T; Sepici Dinçel A; Dumlu EG; Kanbak O
Drug Des Devel Ther; 2017; 11():677-683. PubMed ID: 28331287
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat.
Tang C; Hu Y; Gao J; Jiang J; Shi S; Wang J; Geng Q; Liang X; Chai X
Life Sci; 2020 Sep; 257():118004. PubMed ID: 32621918
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation.
Si Y; Bao H; Han L; Shi H; Zhang Y; Xu L; Liu C; Wang J; Yang X; Vohra A; Ma D
J Transl Med; 2013 Jun; 11():141. PubMed ID: 23759023
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine Alleviates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting p75NTR-Mediated Oxidative Stress and Apoptosis.
Wang Z; Wu J; Hu Z; Luo C; Wang P; Zhang Y; Li H
Oxid Med Cell Longev; 2020; 2020():5454210. PubMed ID: 33194004
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the P38-MAPK/TXNIP signaling activation in streptozotocin induced diabetic rats.
Yeda X; Shaoqing L; Yayi H; Bo Z; Huaxin W; Hong C; Zhongyuan X
Acta Cir Bras; 2017 Jun; 32(6):429-439. PubMed ID: 28700004
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4
Tao WH; Shan XS; Zhang JX; Liu HY; Wang BY; Wei X; Zhang M; Peng K; Ding J; Xu SX; Li LG; Hu JK; Meng XW; Ji FH
Front Pharmacol; 2022; 13():782466. PubMed ID: 35873574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
